麻豆传媒色情片

News

Study suggests that estrogen may drive nicotine addiction in women

Research findings open the door to targeted therapies for controlling nicotine use
Nancy D. Lamontagne
March 25, 2024

A newly discovered feedback loop involving estrogen may explain why women might become dependent on nicotine more quickly and with less nicotine exposure than men. The research could lead to new treatments for women who are having trouble quitting nicotine-containing products such as cigarettes.

Sally Pauss is a doctoral student at the University of Kentucky College of Medicine in Lexington. She led the project.

A newly discovered feedback loop involving estrogen might explain why it can be harder for women to quit nicotine compared to men. The findings being presenting at Discover BMB in San Antonio could lead to new treatments that help women kick the habit.
A newly discovered feedback loop involving estrogen might explain why it can be harder for women to quit nicotine compared to men. The findings being presenting at Discover BMB in San Antonio could lead to new treatments that help women kick the habit.

“Studies show that women have a higher propensity to develop addiction to nicotine than men and are less successful at quitting,” said Pauss, who is working under the supervision of Terry D. Hinds Jr., an associate professor. “Our work aims to understand what makes women more susceptible to nicotine use disorder to reduce the gender disparity in treating nicotine addiction.”

The researchers found that the sex hormone estrogen induces the expression of olfactomedins, proteins that are suppressed by nicotine in key areas of the brain involved in reward and addiction. The findings suggest that estrogen–nicotine–olfactomedin interactions could be targeted with therapies to help control nicotine consumption.

Pauss will present the research at , the annual meeting of the 麻豆传媒色情片 and 麻豆传媒色情片 Biology, which will be held March 23–26 in San Antonio.

“Our research has the potential to better the lives and health of women struggling with substance use,” she said. “If we can confirm that estrogen drives nicotine seeking and consumption through olfactomedins, we can design drugs that might block that effect by targeting the altered pathways. These drugs would hopefully make it easier for women to quit nicotine.”

For the new study, the researchers used large sequencing datasets of estrogen-induced genes to identify genes that are expressed in the brain and exhibit a hormone function. They found just one class of genes that met these criteria: those coding for olfactomedins. They then performed a series of studies with human uterine cells and rats to better understand the interactions between olfactomedins, estrogen and nicotine. The results suggested that estrogen activation of olfactomedins — which is suppressed when nicotine is present — might serve as a feedback loop for driving nicotine addiction processes by activating areas of the brain’s reward circuitry such as the nucleus accumbens.

The researchers are now working to replicate their findings and definitively determine the role of estrogen. This knowledge could be useful for those taking estrogen in the form of oral contraceptives or hormone replacement therapy, which might increase the risk of developing a nicotine use disorder.

The investigators also want to determine the exact olfactomedin-regulated signaling pathways that drive nicotine consumption and plan to conduct behavioral animal studies to find out how manipulation of the feedback loop affects nicotine consumption.

Sally Pauss will present this research during a poster session from 4:30–6:30 p.m. CDT on Monday, March 25, in the exhibit hall of the Henry B. Gonz谩lez Convention Center (Poster Board No. 152) (). 

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Nancy D. Lamontagne

Nancy D. Lamontagne is a science writer and editor at Creative Science Writing based in Chapel Hill, North Carolina.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Can a hair-loss drug prevent heart disease?
Journal News

Can a hair-loss drug prevent heart disease?

Sept. 17, 2024

With the approved medication finasteride, researchers in Illinois may have found a new way to kill two birds with one stone.

These proteins have been secretly managing your cells
News

These proteins have been secretly managing your cells

Sept. 15, 2024

Scientists have long known that histones spool DNA and help regulate genes. They may be doing a lot more.

At the Salton Sea, uncovering the culprit of lung disease
News

At the Salton Sea, uncovering the culprit of lung disease

Sept. 14, 2024

Scientists have long suspected a link between the dust and poor respiratory health. According to recent findings, the prime suspect is a naturally occurring toxin.

From the journals: MCP
Journal News

From the journals: MCP

Sept. 13, 2024

The importance of sharing proteomics data. Detecting nitrotyrosine-containing proteins. Analyzing yeast proteasomes. Read about these recent articles.

Using a network to snare the cause of kidney disease
Journal News

Using a network to snare the cause of kidney disease

Sept. 10, 2024

A microfluidic device that mimics blood capillaries may help in early detection, and proper measures could reduce the risk of renal failures.

All about cholesterol
News

All about cholesterol

Sept. 8, 2024

The latest science on how blood levels of HDL, LDL and more relate to cardiovascular health.